Passage Bio, Inc. (PASG) Financials

PASG Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 169.3 million 43.0 million
2023-06-30 193.7 million 43.3 million
2023-03-31 213.2 million 42.9 million
2022-12-31 243.5 million 42.2 million

PASG Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -19.2 million 2.8 million
2023-06-30 -17.2 million 3.7 million
2023-03-31 -22.5 million 2.8 million
2022-12-31 -24.5 million 3.5 million

PASG Net Income

No data available :(

PASG Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 132.8 million - 26.5 million
2023-06-30 151.5 million - 26.7 million
2023-03-31 167.8 million - 27.0 million
2022-12-31 189.6 million - 27.1 million

PASG Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 54.8 million
2023-06-30 54.7 million
2023-03-31 54.6 million
2022-12-31 54.4 million

PASG Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 4000 15.1 million 8.2 million -
2023-06-30 103000 17.3 million 8.1 million -
2023-03-31 26000 16.8 million 19.0 million -
2022-12-31 474000 17.7 million 10.6 million -

PASG Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 1.0 million
2023-06-30 - 978000
2023-03-31 - 978000
2022-12-31 - 946000

PASG

Price: $1.35

52 week price:
0.58
1.79

Earnings Per Share: -1.86 USD

P/E Ratio: -0.49

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 271900

Market Capitalization: 73.4 million

Links: